Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Valencia Mendoza, Atanacio ^a   Bertozzi, Stefano M ^a,b,c   Gutierrez, Juan Pablo ^a   Itzler, Robbin ^d  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRO DE INVESTIGACIÓN Y DOCENCIA ECONÓMICAS   (Mexico)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILDHOOD MORTALITY; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEATH; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; FATALITY; GASTROENTERITIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL CARE; MEXICO; MORBIDITY; PATIENT MONITORING; POVERTY; PRESCHOOL CHILD; PREVALENCE; RISK REDUCTION; SENSITIVITY ANALYSIS; SEROTYPE; VACCINATION; VIRUS INFECTION; DIARRHEA; ECONOMICS; HEALTH CARE PLANNING; IMMUNOLOGY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; ROTAVIRUS; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; DIARRHEA; HEALTH CARE COSTS; HEALTH PRIORITIES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MEXICO; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 51249115369     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-103     Document Type: Article

References (17)

1. Rodriguez WJ Kim HW Arrobio JO Brandt CD Chanock RM Kapikian AZ Wyatt RG Parrott RH Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children J Pediatr 1977, 91(2):188-93 10.1016/S0022-3476(77)80810-X 195031
2. Sabbaj L De Petre EE Gómez JA Sordo ME Rotavirus en la diarrea aguda Arch Argent Pediatr 2001, 99(6):486-90
3. Uhnoo I Svensson L Clinical and epidemiological features of acute infantile gastroenteritis associated with human rotavirus subgroups 1 and 2 J Clin Microbiol 1986, 23(3):551-5 268692 3007567
4. Parashar UD Hummelman EG Bresee JS Miller MA Glass RI Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 2003, 9(5):565-72 12737740
5. Blanck RE Greenberg HB Kapikian AZ Brown KH Becker S Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh J Infect Dis 1982, 145(4):483-9 6279734
6. Mota-Hernández F Gutiérrez-Camacho C Villa-Contreras S Calva-Mercado J Arias CF Padilla-Noriega L Guiscafré-Gallardo H [Prognosis of rotavirus diarrhea] Salud Publica Mex 2001, 43(6):524-8 11816226
7. Cook SM Glass RI LeBaron CW Ho MS Global seasonality of rotavirus infection Bull World Health Organ 1990, 68(2):171-7 1694734
8. Vesikari T Itzler R Matson DO Santosham M Christie CD Coia M Cook JR Koch G Heaton P Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries) Int J Infect Dis 2007, 11(Suppl 2):S29-35 10.1016/ S1201-9712(07)60019-8 18162243
9. Marie-Cardine A Gourlain K Mouterde O Castignolles N Hellot MF Mallet E Buffet-Janvresse C Epidemiology of Acute Viral Gastroenteritis in Children Hospitalized in Rouen, France Clin Infect Dis 2002, 34(9):1170-8 10.1086/339807 11941542
10. Rivest P Proulx M Lonergan G Lebel MH Bédard L Hospitalisations for gastroenteritis: The role of rotavirus Vaccine 22(15-16):2013-7 2004 May 7 15121314
11. Velázquez FR Garcia-Lozano H Rodriguez E Cervantes Y Gómez A Melo M Anaya L Ovalle JC Torres J Diaz De Jesus B Alvarez-Lucas C Breuer T Muñoz O Kuri P Diarrhea morbidity and mortality in Mexican children: Impact of rotavirus disease Pediatr Infect Dis J 2004, 23(10 Suppl):S149-55 15502694
12. Velázquez FR Matson DO Calva JJ Guerrero L Morrow AL Carter-Campbell S Glass RI Estes MK Pickering LK Ruiz-Palacios GM Rotavirus infections in infants as protection against subsequent infections N Engl J Med 335(14):1022-8 1996 Oct 3 10.1056/ NEJM199610033351404 8793926
13. Secretaría de Salud Salud México 2004: Información para la rendición de cuentas. Mexico 2005 http://www.salud.gob.mx/unidades/evaluacion/saludmex2004/sm2004.pdf ISBN 970-721-267-5
14. Mota-Hernández F Calva JJ Gutiérrez-Camacho C Villa-Contreras S Arias CF Padilla-Noriega L Guiscafré-Gallardo H de Lourdes Guerrero M López S Muñoz O Contreras JF Cedillo R Herrera I Puerto FI Rotavirus diarrhea severity is related to the VP4 type in Mexican children J Clin Microbiol 2003, 41(7):3158-62 165316 12843057 10.1128/JCM.41.7.3158-3162.2003
15. Nafate A Determinación de costos por caso de diarrea en menores de cinco años atendidos en tres subsistemas de atención a la salud en Morelos, México MSc thesis Escuela de Salud Pública de México 2006
16. República Mexicana: Probabilidades de fallecer por sexo y edad, 2005-2050 http://www.conapo.gob.mx/00cifras/proy/RM.xls
17. Informe sobre desarrollo humano para México 2005 del Programa de las Naciones Unidas para el Desarrollo http://saul.nueve.com.mx/informes/ index.html